dapa-ckd: does confirmed renoprotection make the case for first-line sglt2 inhibition? | luigi gnudi
Published 3 years ago • 1.2K plays • Length 6:11Download video MP4
Download video MP3
Similar videos
-
8:14
dapa-ckd: renal benefits of sglt2 inhibition in people with and without diabetes | hiddo heerspink
-
6:57
how does dapagliflozin work? understanding sglt2 inhibitors.
-
9:06
sglt2 inhibitors in chronic kidney disease
-
16:24
how sglt2 inhibitors protect the kidney
-
7:38
dapa ckd
-
4:42
how to slow down polycystic kidney disease (adpkd) progression?
-
19:53
ức chế sglt2: giải pháp bệnh thận đái tháo đường sau 20 năm
-
46:01
ckd e-learning - sglt-2 inhibitors and ckd - 05.19.21
-
4:08
newer drugs for kidney and cardiovascular diseases by dr. luigi gnudi
-
13:17
esc 2020 discussion: the dapa-ckd study — prof david wheeler & dr harriette van spall
-
49:14
sglt2 inhibitors: can these drugs slow the progression of chronic kidney disease?
-
2:03
dapagliflozin clinically and cost effective in patients with chronic kidney disease dapa ckd trial
-
42:28
dapa hf dapa ckd #dapackdtrial #sglt2idapa #pcmanoria
-
9:55
how sglt2 inhibitors protect the kidney in patients with diabetes mellitus?
-
2:53
dapa ckd trial
-
1:05:08
new glucose-lowering drugs and kidney protection in ckd
-
10:55
what are sglt2 inhibitors and how do they affect kidney disease?
-
39:11
state of the art: diabetes management with respect to cvd and ckd in 2018
-
9:32
dapa ckd - trial
-
2:17
esc tv at esc congress 2020 - dapa-ckd (discussant)
-
1:56
semaglutide, chronic kidney disease, and diabetes | nejm